Occurrence and Effects of Plastic Additives on Marine Environments and Organisms: a Review
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
OFR Staff Plan
Staff Briefing Package Project Plan: Organohalogen Flame Retardant Chemicals Assessment July 1, 2020 CPSC Consumer Hotline and General Information: 1-800-638-CPSC (2772) CPSC's Web Site: http://www.cpsc.gov THIS DOCUMENT HAS NOT BEEN REVIEWED CLEARED FOR PUBLIC RELEASE OR ACCEPTED BY THE COMMISSION UNDER CPSA 6(b)(1) Acknowledgments The preparation, writing, and review of this report was supported by a team of staff. We acknowledge and thank team members for their significant contributions. Michael Babich, Ph.D., Directorate for Health Sciences Charles Bevington, M.P.H., Directorate for Health Sciences Xinrong Chen, Ph.D., D.A.B.T., Directorate for Health Sciences Eric Hooker, M.S., D.A.B.T., Directorate for Health Sciences Cynthia Gillham, M.S., Directorate for Economic Analysis John Gordon, Ph.D., Directorate for Health Sciences Kristina Hatlelid, Ph.D., M.P.H., Directorate for Health Sciences Barbara Little, Attorney, Office of the General Counsel Joanna Matheson, Ph.D., Directorate for Health Sciences ii THIS DOCUMENT HAS NOT BEEN REVIEWED CLEARED FOR PUBLIC RELEASE OR ACCEPTED BY THE COMMISSION UNDER CPSA 6(b)(1) Table of Contents Briefing Memo ............................................................................................................................... iv 1. Executive summary .............................................................................................................. 5 2. Introduction ......................................................................................................................... -
Survey and Risk Assessment of Chemical Substances in Rugs for Children
Survey and risk assessment of chemical substances in rugs for children Survey of chemical substances in consumer products No. 147, 2016 Titel: Forfattere: Survey and risk assessment of chemical substances Helene Bendstrup Klinke, Sie Woldum Tordrup, Thomas Witterseh, in rugs for children Johnny Rodam, Nils H. Nilsson -Danish Technological Institute Poul Bo Larsen - DHI Udgiver: The Danish Environmental Protection Agency Strandgade 29 1401 København K www.mst.dk År: ISBN nr. 2016 978-87-93435-98-8 Disclaimer: The Danish Environmental Protection Agency publishes reports and papers about research and development projects within the environmental sector, financed by the Agency. The contents of this publication do not necessarily represent the official views of the Danish Environmental Protection Agency. By publishing this report, the Danish Environmental Protection Agency expresses that the content represents an important contribution to the related discourse on Danish environmental policy. Sources must be acknowledged. 2 Survey and risk assessment of chemical substances in rugs for children Contents Contents .................................................................................................................... 3 Preface ...................................................................................................................... 6 Summary and Conclusion .......................................................................................... 7 Sammenfatning og konklusion ................................................................................ -
Hexabromocyclododecane (HBCD) Action Plan
U.S. Environmental Protection Agency 8/18/2010 Hexabromocyclododecane (HBCD) Action Plan I. Overview HBCD is a brominated flame retardant found world-wide in the environment and wildlife. Human exposure is evidenced from its presence in breast milk, adipose tissue and blood. It bioaccumulates and biomagnifies in the food chain. It persists and is transported long distances in the environment, and highly toxic to aquatic organisms. It also presents potential human health concerns based on animal test results indicating potential reproductive, developmental and neurological effects. For these reasons, the Environmental Protection Agency (EPA) intends to consider initiating action under the Toxic Substances Control Act to address the manufacturing, processing, distribution in commerce, and use of HBCD. As part of the Agency's efforts to address HBCD, EPA also intends to evaluate the potential for disproportionate impact on children and other sub-populations. II. Introduction As part of EPA’s efforts to enhance the existing chemicals program under the Toxic Substances Control Act (TSCA)1, the Agency has identified certain widely recognized chemicals, including HBCD, for action plan development based on their presence in humans; persistent, bioaccumulative, and toxic (PBT)2 characteristics; use in consumer products; production volume; or other similar factors. This Action Plan is based on EPA’s initial review of readily available use, exposure, and hazard information on HBCD. EPA considered which of the various authorities provided under TSCA and other statutes might be appropriate to address potential concerns with HBCD in developing the Action Plan. The Action Plan is intended to describe the courses of action the Agency plans to pursue in the near term to address its concerns. -
Analysis of PFAS, Phthalates, Alternative Plasticizers and Organophosphate Esters in Sludge
No. U 6235 January 2020 Analysis of PFAS, phthalates, alternative plasticizers and organophosphate esters in sludge Commissioned by Naturvårdsverket Georgios Giovanoulis, Jenny Aasa, Jon Benskin, Merle Plassmann, Minh Nguyen, Raed Awad and Robin Vestergren Author: Georgios Giovanoulis, Jenny Aasa, Minh Nguyen, and Robin Vestergren Commissioned by Naturvårdsverket Project Participants: Naturvårdsverket Report number: U 6235 © IVL Swedish Environmental Research Institute 2020 IVL Swedish Environmental Research Institute Ltd., P.O Box 210 60, S-100 31 Stockholm, Sweden Phone +46-(0)10-788 65 00 // www.ivl.se This report has been reviewed and approved in accordance with IVL's audited and approved management system. Table of contents Summary ................................................................................................................................ 4 Sammanfattning ..................................................................................................................... 5 1 Introduction ..................................................................................................................... 6 2 Materials & Methods ...................................................................................................... 8 2.1 Sampling ............................................................................................................................................ 8 2.2 Extraction and analysis of phthalates, alternative plasticizers and organophosphate esters ................................................................................................................................................. -
No 1223/2009 of the EUROPEAN PARLIAMENT and of the COUNCIL of 30 November 2009 on Cosmetic Products (Recast) (Text with EEA Relevance) (OJ L 342, 22.12.2009, P
02009R1223 — EN — 03.12.2020 — 025.001 — 1 This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document ►B REGULATION (EC) No 1223/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 30 November 2009 on cosmetic products (recast) (Text with EEA relevance) (OJ L 342, 22.12.2009, p. 59) Amended by: Official Journal No page date ►M1 Commission Regulation (EU) No 344/2013 of 4 April 2013 L 114 1 25.4.2013 ►M2 Commission Regulation (EU) No 483/2013 of 24 May 2013 L 139 8 25.5.2013 ►M3 Commission Regulation (EU) No 658/2013 of 10 July 2013 L 190 38 11.7.2013 ►M4 Commission Regulation (EU) No 1197/2013 of 25 November 2013 L 315 34 26.11.2013 ►M5 Commission Regulation (EU) No 358/2014 of 9 April 2014 L 107 5 10.4.2014 ►M6 Commission Regulation (EU) No 866/2014 of 8 August 2014 L 238 3 9.8.2014 ►M7 Commission Regulation (EU) No 1003/2014 of 18 September 2014 L 282 1 26.9.2014 ►M8 Commission Regulation (EU) No 1004/2014 of 18 September 2014 L 282 5 26.9.2014 ►M9 Commission Regulation (EU) 2015/1190 of 20 July 2015 L 193 115 21.7.2015 ►M10 Commission Regulation (EU) 2015/1298 of 28 July 2015 L 199 22 29.7.2015 ►M11 Commission Regulation (EU) 2016/314 of 4 March 2016 L 60 59 5.3.2016 ►M12 Commission Regulation (EU) -
Bsef Factsheet TBBPA 24 09 Os9
HBCD Factsheet Brominated Flame retardant October 2012 Hexabromocyclododecane HBCD Factsheet Hexabromocyclododecane > Introduction Hexabromocyclododecane (HBCD) 1 is a brominated flame retardant used for many years mainly in thermal insulation foams and in textile coatings. In these applications, HBCD is a unique flame retardant protecting human lives and property from fire. Summary: HBCD is used in industrial applications with proven socio-economic benefits due to their key role in both fire safe ty and energy efficiency. HBCD has undergone an EU scientific assessment which identified no risk to consumers. At European level, HBCD is currently being reviewed under the REACH procedure. In this context, HBCD has been identified as a Substance of Very High Concern (SVHC) 2 and is subject to the Authorisation procedure (REACH Annex XIV) 3. HBCD is also being reviewed under the UNEP Stockholm Convention on Persistent Organic Pollutants and the UNECE Convention on Long-Range Transboundary Air Pollution on Persistent Organic Pollutants. Given the risks identified for the environment, HBCD producers and users are committed to ensuring a responsible use of HBCD and have launched voluntary programmes aiming at controlling and reducing emissions to the envi ronment. > Applications and Fire safety POLYSTYRENE (PS) HBCD provides a high degree of INSULATION FOAMS flame retardancy when used at very low concentrations. HBCD’s main use is in Expanded and Extruded Polystyrene (EPS and XPS) While alternatives to HBCD in EPS insulation foam boards which are widely and XPS have been identified, these are used by the construction sector. at variously advanced development stages. It will take several years before EPS and XPS insulation foams play a sufficient volume of HBCD alternatives a key role in helping governments covering the needs of the market meet a significant part of global, becomes commercially available. -
Aggregate Exposures to Phthalates in Humans
Aggregate Exposures to Phthalates in Humans July 2002 ACKNOWLEDGMENTS Contributors Joseph DiGangi, PhD, USA, Ted Schettler MD, MPH, USA Madeleine Cobbing, UK Mark Rossi, MA, USA Reviewers HCWH thanks the following individuals for reviewing an earlier draft of this report. Their comments and sug- gestions were invaluable and substantially improved the manuscript. We are grateful for their contribution. Their review, however, does not constitute endorsement of the report or its conclusions. Two additional reviewers chose to remain anonymous. Earl Gray PhD Michael McCally MD, PhD The contributing authors would also like to thank Cecilia DeLoach, Tracey Easthope, Per Rosander, Jamie Harvie and Charlotte Brody for their editing and proofreading of this report. Health Care Without Harm 1755 S St. NW, Suite 6B • Washington, DC 20009 • www.noharm.org • 202-234-0091 Contents Acknowledgements......................................................................................ii Executive Summary.....................................................................................1 Abbreviations..............................................................................................4 Preface......................................................................................................5 Introduction................................................................................................6 Phthalates in Consumer Products.................................................................9 Phthalate Toxicity ......................................................................................14 -
ANALYSIS of ALTERNATIVES Non-Confidential Report
ANALYSIS OF ALTERNATIVES non-confidential report Legal name of applicant(s): DEZA, A.S. Submitted by: DEZA, A.S. Substance: BIS (2-ETHYLHEXYL ) PHTHALATE (DEHP) Use title: Formulation of DEHP in compounds, dry-blends and plastisol formulations Industrial use in polymer processing by calendering, spread coating, extrusion, injection moulding to produce PVC articles [except erasers, sex toys, small household items (<10cm) that can be swallowed by children, clothing intended to be worn against the bare skin; also toys, cosmetics and food contact material (restricted under other EU regulation)] Use number: Uses 1 and 2 ANALYSIS OF ALTERNATIVES © DEZA, a.s. 2013 The information in this document is the property of DEZA, a.s. and may not be copied, communicated to a third party, or used for any purpose other than that for which it is supplied, without the express written consent of DEZA, a.s. While the information is given in good faith based upon the latest information available to DEZA, a.s., no warranty or representation is given concerning such information, which must not be taken as establishing any contractual or other commitment binding upon DEZA, a.s or any of its subsidiary or associated companies. ii ANALYSIS OF ALTERNATIVES CONTENTS 1 SUMMARY ............................................................................................................................................................ 1 1.1 Background to this Application for Authorisation ......................................................................................... -
Triphenyl Phosphate (TPP)
EPA Document# EPA-740-R-20-010 August 2020 United States Office of Chemical Safety and Environmental Protection Agency Pollution Prevention Final Scope of the Risk Evaluation for Triphenyl Phosphate (TPP) CASRN 115-86-6 August 2020 TABLE OF CONTENTS ACKNOWLEDGEMENTS ......................................................................................................................6 ABBREVIATIONS AND ACRONYMS ..................................................................................................7 EXECUTIVE SUMMARY .......................................................................................................................9 1 INTRODUCTION ............................................................................................................................12 2 SCOPE OF THE EVALUATION ...................................................................................................12 2.1 Reasonably Available Information ..............................................................................................12 Search of Gray Literature ...................................................................................................... 13 Search of Literature from Publicly Available Databases (Peer-Reviewed Literature) .......... 14 Search of TSCA Submissions ................................................................................................ 24 2.2 Conditions of Use ........................................................................................................................24 Categories -
HEXABROMOCYCLODODECANE (HBCD) CAS Reg
Docket ID Number: EPA-HQ-OPPT-2016-0735 Comments to the U.S. Environmental Protection Agency (EPA) on the Scope of its Risk Evaluation for the TSCA Work Plan Chemicals: CYCLIC ALIPHATIC BROMIDE CLUSTER or HEXABROMOCYCLODODECANE (HBCD) CAS Reg. Nos. 25637-99-4, 3194-55-6, 3194-57-8 Submitted on March 15, 2017 by Safer Chemicals, Healthy Families Environmental Health Strategy Center Healthy Building Network I. INTRODUCTION The Toxic Substances Control Act (TSCA), as amended in June 2016, requires the U.S. Environmental Protection Agency (EPA) to determine whether existing chemical substances pose an unreasonable risk to human health and the environment, both generally and for vulnerable subpopulations, without consideration of costs or other non- risk factors. When unreasonable risk is found, EPA must enact restrictions on the production (including both domestic manufacture and import), processing, distribution in commerce, use and/or disposal of that chemical, and/or materials and articles that contain that chemical, that are sufficient to extinguish such unreasonable risk. Congress directed EPA to launch the risk evaluation process expeditiously. Accordingly, in section 6(b)(2)(A) of TSCA, it directed EPA to assure that evaluations are initiated within six months of the law’s enactment on 10 substances drawn from the 2014 TSCA Work Plan list. EPA designated these 10 substances on December 19, 2016, and is now developing scoping documents for its evaluations. EPA’s initial risk evaluations will provide an early test of the effectiveness of new law. It is therefore critical that they reflect the best information available on hazard and exposure, are based on a comprehensive understanding of the chemicals’ conditions of use, and employ sound, precautionary methodologies that fully capture the risks they pose to human health and the environment. -
Non-Toxic Healthcare - Second Edition (2019) Non-Toxic Healthcare - Second Edition (2019) 3 Foreword Executive Summary
NON- TOXIC HEALTH CARE: Alternatives to Hazardous Chemicals in Medical Devices: Phthalates and Bisphenol A SECOND EDITION (2019) TABLE OF CONTENTS Foreword 4 Executive Summary 5 Introduction 6 Hazard of chemicals contained in medical devices 6 Hazards for human health 8 Exposure through medical devices 8 Hazards for the environment 11 The European legal framework on hazardous chemicals in medical devices 11 Why update this report now? 15 Chapter 1: Substituting hazardous chemicals in Medical Devices 16 Governmental Initiatives 17 Non-Governmental Initiatives 17 Chapter 2: Alternatives to phthalates 19 Chapter 3: Alternatives to BPA 20 Chapter 4: Best practices in European healthcare 21 Chapter 5: The health impact of plastics in healthcare 22 General background 22 Plastics in healthcare - Medical plastics 28 Impacts of medical plastics 29 Case studies of plastic waste management in European hospitals 32 Initiatives from the medical devices industry 32 The way forward / The urgency to act on plastics 34 Chapter 6: Conclusions and recommendations 36 Conclusions 36 HCWH Europe’s Recommendations 37 References 39 2 NON-TOXIC HEALTHCARE - SECOND EDITION (2019) NON-TOXIC HEALTHCARE - SECOND EDITION (2019) 3 FOREWORD EXECUTIVE SUMMARY Modern healthcare makes use of a wide range of HCWH Europe promotes the substitution of harm- Medical devices play a critical role in healthcare but Within this report, HCWH Europe examines the plastic-based medical products to provide high ful substances by demonstrating that many alter- may contain hazardous substances in their com- health impact of plastics in healthcare, and pre- quality and effective treatment to patients. As a natives with safer toxicological profiles are available position that can leach into patients during their sents a number of recommendations for policy consequence high volumes of plastic single-use on the market. -
LOUS 2013 Hoering Phthalates
Survey of selected phthalates Part of the LOUS-review Version of Public Hearing October 2013 1 Survey of selected phthalates 1 Title: Authors and contributors : Survey of selected phthalates Sonja Hagen Mikkelsen Jakob Maag Jesper Kjølholt Carsten Lassen Christian Nyander Jeppesen Anna Juliane Clausen COWI A/S, Denmark Published by: The Danish Environmental Protection Agency Strandgade 29 1401 Copenhagen K Denmark www.mst.dk/english Year: 2013 ISBN no. [xxxxxx] Disclaimer: When the occasion arises, the Danish Environmental Protection Agency will publish reports and papers concerning research and development projects within the environmental sector, financed by study grants provided by the Danish Environmental Protection Agency. It should be noted that such publications do not necessarily reflect the position or opinion of the Danish Environmental Protection Agency. However, publication does indicate that, in the opinion of the Danish Environmental Protection Agency, the content represents an important contribution to the debate surrounding Danish environmental policy. While the information provided in this report is believed to be accurate, the Danish Environmental Protection Agency disclaims any responsibility for possible inaccuracies or omissions and consequences that may flow from them. Neither the Danish Environmental Protection Agency nor COWI or any individual involved in the preparation of this publication shall be liable for any injury, loss, damage or prejudice of any kind that may be caused by persons who have acted based on